Pre-eclampsia: a Life-threatening Pregnancy Syndrom

被引：0

作者：

Brazdova, Andrea ^{[1
,2
]}

Keprova, Alena ^{[3
]}

Zidkova, Jarmila ^{[2
]}

Madar, Jindrich ^{[4
]}

机构：

[1] Univ Paris 06, Cordelier Res Ctr, Paris, France

[2] Prague Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic

[3] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic

[4] Inst Care Mother & Child, Prague, Czech Republic

来源：

BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY | 2014年 / 57卷 / 05期

关键词：

placenta; pre-eclampsia; pregnancy; oxidative stress; OXIDATIVE STRESS; ANTIOXIDANT STATUS;

D O I：

10.1590/S1516-8913201402449

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Pre-eclampsia is a serious pathological state affecting 5-10% of pregnant women. Currently, it is diagnosed in the second half of pregnancy, particularly after the 20th week. Symptoms mostly correspond to the changes of blood vessels and kidneys. The severity of pre-eclampsia is proportional to symptomatic manifestations, thus the more symptoms present, the higher is of pre-eclampsia development. Although there are several studies dealing with pre-eclampsia pathology, the complete etiology is still unknown. In this review paper, several theories are presented and discussed.

引用

页码：701 / 705

页数：5

共 25 条

[1]

Antony J, 1996, CURRENT OBSTET GYNAE, V6, P98

[2]

Arbogast BW, 1996, MOL MECH PREECLAMPSI

[3]

Arnostova A, 2007, KLIN BIOCH METAB, V15, P200

[4] Pre-eclampsia: Clinical manifestations and molecular mechanisms [J].

Baumwell, Suzanne ;

Karumanchi, S. Ananth .

NEPHRON CLINICAL PRACTICE, 2007, 106 (02) :C72-C81

[5] Inflammation and pre-eclampsia [J].

Borzychowski, A. M. ;

Sargent, I. L. ;

Redman, C. W. G. .

SEMINARS IN FETAL & NEONATAL MEDICINE, 2006, 11 (05) :309-316

[6]

Brown MA., 2001, HYPERTENS PREGNANCY, V20, P9

[7] The lag phase [J].

Cadenas, E ;

Sies, H .

FREE RADICAL RESEARCH, 1998, 28 (06) :601-609

[8]

Cai ZZ, 2009, ASIA PAC J CLIN NUTR, V18, P81

[9] A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation [J].

Clark, DE ;

Smith, SK ;

He, YL ;

Day, KA ;

Licence, DR ;

Corps, AN ;

Lammoglia, R ;

Charnock-Jones, DS .

BIOLOGY OF REPRODUCTION, 1998, 59 (06) :1540-1548

[10] VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia [J].

Cooper, JC ;

Sharkey, AM ;

CharnockJones, DS ;

Palmer, CR ;

Smith, SK .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (12) :1191-1196

← 1 2 3 →